Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130201011M |
| Application |
Cancer Marker |
The kit has been designed for the quantitative determination of Cancer Antigen 19-9 (CA19-9) in human serum. The method can be used for samples over the range of 1.0-1,000 U/ml. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).
High Sensitivity and Specificity for Clinical MonitoringThe MAGLUMI CA 19-9 (CLIA) kit provides laboratories with high specificity and sensitivity in detecting and quantifying CA 19-9, a vital tumor marker for pancreatic and gastrointestinal cancer. Its precise chemiluminescent technology enables reliable monitoring and aids early disease detection and effective treatment assessment.
Efficient Workflow and Easy IntegrationReady-to-use liquid reagents and an automated barcode system simplify preparation and traceability, reducing hands-on time for laboratory staff. The kit supports high throughput and is compatible with all Snibe MAGLUMI series analyzers, ensuring seamless integration into routine clinical laboratory operations without compromising accuracy or productivity.
FAQs of Snibe MAGLUMI CA 19-9 (CLIA):
Q: How is the Snibe MAGLUMI CA 19-9 (CLIA) kit typically used in clinical laboratories?
A: This kit is used for the in vitro quantitative determination of the CA 19-9 tumor marker in human serum or plasma. It is primarily utilized to monitor and manage patients with pancreatic and gastrointestinal cancers, providing critical information for disease progression and therapeutic response.
Q: What is the principle behind the test, and how does it ensure accurate results?
A: The assay operates on a two-step Chemiluminescent Immunoassay (CLIA) principle, offering high sensitivity and specificity. Internal quality control, traceable calibrators, and automated reagent identification help maintain reliable and accurate quantitative results.
Q: When should the reagents and controls be calibrated and quality checked?
A: Calibration should be performed as defined by the standard calibration procedure for your laboratorys MAGLUMI analyzer. Internal quality control is included to monitor assay performance with every run, ensuring continual result integrity.
Q: Where can this kit be used, and on which equipment is it compatible?
A: It is intended for use in clinical laboratories and hospitals. The kit is specifically compatible with Snibe MAGLUMI series Immunoassay Analyzers, ensuring optimal performance and workflow automation.
Q: What benefits does the MAGLUMI CA 19-9 (CLIA) kit offer laboratory professionals?
A: Laboratory professionals benefit from ready-to-use reagents, high-throughput capability, automated barcode-based reagent identification, and a measurement range of 0.5 to 1000 U/mL, all contributing to streamlined workflows and dependable results.
Q: How should the kit and its reagents be stored, and what is the shelf life?
A: Reagents and kit components should be stored at 28C, strictly avoiding freezing. When unopened and properly stored, the shelf life is 12 months, as indicated on the product label.
Q: What traceability and documentation features are included in the kit?
A: Each reagent vial features a lot number for full traceability, and calibrators and controls are reference-traceable, supporting regulatory compliance and consistent quality assurance.